CN102864114B - Strain for highly yielding enramycin, and preparation method and application thereof - Google Patents
Strain for highly yielding enramycin, and preparation method and application thereof Download PDFInfo
- Publication number
- CN102864114B CN102864114B CN 201210399132 CN201210399132A CN102864114B CN 102864114 B CN102864114 B CN 102864114B CN 201210399132 CN201210399132 CN 201210399132 CN 201210399132 A CN201210399132 A CN 201210399132A CN 102864114 B CN102864114 B CN 102864114B
- Authority
- CN
- China
- Prior art keywords
- enramycin
- strain
- bacterial strain
- dcs067
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- NJCUSQKMYNTYOW-MWUYRYRWSA-N enramicina Chemical compound O.N1C(=O)NC(=O)C(C=2C=C(Cl)C(O)=C(Cl)C=2)NC(=O)C(CO)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(CC2N=C(N)NC2)NC(=O)C(CCCNC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C(C)O)NC(=O)N(CCCCN)C(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)/C=C/C=C/CCCCC(C)CC)C(C)OC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C)NC(=O)C1CC1CNC(N)=N1 NJCUSQKMYNTYOW-MWUYRYRWSA-N 0.000 title claims abstract description 33
- 108700041171 enramycin Proteins 0.000 title claims abstract description 33
- 229950003984 enramycin Drugs 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title description 15
- 230000001580 bacterial effect Effects 0.000 claims description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 241001655322 Streptomycetales Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 230000000855 fungicidal effect Effects 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 8
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 229920002494 Zein Polymers 0.000 claims description 6
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 239000011790 ferrous sulphate Substances 0.000 claims description 6
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 6
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 6
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000005019 zein Substances 0.000 claims description 6
- 229940093612 zein Drugs 0.000 claims description 6
- 241000187747 Streptomyces Species 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 102000004139 alpha-Amylases Human genes 0.000 claims description 4
- 108090000637 alpha-Amylases Proteins 0.000 claims description 4
- 229940024171 alpha-amylase Drugs 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 239000011592 zinc chloride Substances 0.000 claims description 4
- 235000005074 zinc chloride Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 10
- 238000012216 screening Methods 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 238000009629 microbiological culture Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 26
- 239000000725 suspension Substances 0.000 description 18
- 230000001954 sterilising effect Effects 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000011218 seed culture Methods 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 229920002306 Glycocalyx Polymers 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 210000004517 glycocalyx Anatomy 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 206010010254 Concussion Diseases 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 229960001701 chloroform Drugs 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000002655 kraft paper Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 108010046845 tryptones Proteins 0.000 description 2
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940063650 terramycin Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a strain for highly yielding enramycin, simultaneously provides a screening method of the strain, and provides application of the strain in enramycin production. The preserving number of the strain DCS067 for highly yielding enramycin is CGMCCONO: 6220, the preserving unit is China General Microbiological Culture Collection Center (CGMCC), and the preserving date is June 14, 2012. The DCS067 strain enables production rate of enramycin to be improved by 47.80%.
Description
Technical field
The present invention relates to a kind ofly for the production of antibiotic bacterial strain, specifically, relate to bacterial strain of a kind of high yield enramycin and its preparation method and application.
Background technology
Enramycin is a kind of ring type polypeptide class microbiotic that is combined into by tens seed amino acids and unsaturated fatty acids that is produced by true sterilization streptomycete (Streptomyces fungicidious) fermentation.Mostly screened from wild strain for the production of the fungicidal streptomycete bacterial strain of enramycin in the past and obtain, its production level is lower.Chinese patent ZL 201010528367.2 discloses a kind of fungicidal streptomycete mutant strain FYFJ03(preserving number CGMCC No.4113), its screening method is: at first adopt 5-bromouracil to lure the starting strain sudden change into, produce mutant strain, then adopt streptococcus aureus, according to the biological value method, mutant strain is screened, obtain the bacterial strain of high yield enramycin.Although the method has improved the throughput of bacterial strain to a certain extent, owing to only having adopted chemomorphosis, and screening mode is single, so the raising of bacterial strain throughput is limited.
Summary of the invention
The bacterial strain that the purpose of this invention is to provide a kind of high yield enramycin provides the screening method of above-mentioned bacterial strains simultaneously, and the application of this bacterial strain in enramycin is produced is provided.
For realizing the object of the invention, the invention provides a kind of specific name is that fungicidal streptomycete (Streptomyces fungicidious) DCS067(is hereinafter to be referred as DCS067) the enramycin superior strain, its preserving number is CGMCC No.6220, depositary institution is China Committee for Culture Collection of Microorganisms (CGMCC), and preservation date is on June 14th, 2012.
Its microbial characteristic of DCS067 bacterial strain provided by the present invention is as follows:
The form of single bacterium colony is: colony diameter 2-3mm, and spore grey or white, plentiful.The microscopic examination spore is circular or oval.
The preparation method of DCS067 provided by the invention comprises the following steps:
The preparation of a, spore suspension I: get the starting strain of fungicidal streptomycete, be inoculated on slant medium, cultivated 5-8 days under 28.0 ± 0.5 ℃, relative humidity 40%-60% condition, then add sterilized water, spore is scraped, mixing obtains the spore suspension I;
B, organic solvent are processed: add aseptic organic solvent in the spore suspension I, and standing after vibration, layering, water intaking obtains the spore suspension II mutually; Described vibration can be adopted vortex oscillation device vibration 15-60 s, and time of repose is preferably 15-30min.
C, ultraviolet mutagenesis: the spore suspension II being placed in the culture dish of sterilization, is to shine 45-60s under the ultraviolet lamp of 254nm in wavelength; During irradiation, be preferably vertical range 30cm place's irradiation under the ultraviolet lamp of 30W at power.
d, resistance screening: the spore suspension II after mutagenic treatment is coated on contains on antibiotic isolation medium, cultivated 5-8 days under 28.0 ± 0.5 ℃, relative humidity 40%-60% condition, generate the some single bacterium colony with antibiotic resistance, during cultivation, best first day is just put, and second day rises to be inverted and cultivates, the above-mentioned single bacterium colony of difference picking, be inoculated on slant medium, at 28.0 ± 0.5 ℃, cultivate after 5-8 days under relative humidity 40%-60% condition, be inoculated on seed culture medium, at 28.0 ± 0.5 ℃, after cultivating 26-30h under 200 ~ 220 rpm conditions, be inoculated on fermention medium, at 28.0 ± 0.5 ℃, cultivated 9-12 days under 200 ~ 220 rpm conditions, obtain fermented liquid, in employing HPLC method mensuration fermented liquid, enramycin is tired, wherein, bacterial strain corresponding to the highest fermented liquid of tiring is fungicidal streptomycete of the present invention (Streptomyces fungicidious) DCS067.
At first the present invention processes the bacterial strain spore suspension through organic solvent, removed the dirt settlings such as glycocalix, protein matter of spore surface, is conducive to follow-up mutagenesis and screening.This be because strain cell in the growth and breeding process, can form the dirt settling that is mainly formed by glycocalix and protein matter around spore, this type of dirt settling can not only shielding of ultraviolet effect, can also the antibiotic infiltration of overslaugh, simultaneously, the Degradation of Antibiotics enzyme that also contains higher concentration in glycocalix has further stoped the impact of microbiotic on the deep layer spore.Remove above-mentioned dirt settling, spore is exposed in outside atmosphere better.The present invention is in subsequent step, and the mode that has adopted the screening of ultraviolet mutagenesis and antibiotics resistance to combine has overcome the deficiency of single mutagenesis in the past, has further improved the enramycin productive rate of mutant strain.Compare with starting strain, the enramycin productive rate of bacterial strain of the present invention has improved 47.80%.The described spore suspension I of a step of the present invention miospore concentration is preferably 10
11-10
13Individual/mL or absorbance A
600Be 1.0-2.0; Spore suspension under this concentration or absorbancy is easy to remove the dirt settling (glycocalix, protein matter) of spore surface, also has simultaneously good reproductive performance.The described organic solvent of b step of the present invention is the mixture of any one or a few in the phenol of sterilising treatment, trichloromethane, n-hexadecane, normal hexane, octane, n-dodecane, n-Octanol, dimethylbenzene preferably.Wherein, preferred combination is the mixture of phenol and trichloromethane; In mixture, the volume ratio of phenol and trichloromethane is preferably 25:4.When adopting said mixture that the spore suspension I is processed, can remove better glycocalix, the protein matter of spore surface.
Pressing mass volume ratio calculates, the composition of slant medium of the present invention is preferably: the 0.5-1.0% maltitol powder, the 0.05-0.10% dried yeast powder, 0.05-0.10% tuna cream, the 0.06-0.12% Tryptones, 0.1-0.5% sodium-chlor, 1.8-2.2% agar, all the other are water, preferred 0.1 ~ 0.7 μ g/mL of antibiotic content in described separation and Culture, all the other compositions and content are identical with slant medium, and it is that 30% the NaOH aqueous solution is regulated pH to 6.7 ± 0.1 that described slant medium and isolation medium all adopt the quality percentage composition.
Microbiotic preference chain mycin in isolation medium of the present invention.
Pressing mass volume ratio calculates, the described seed culture based component of d step of the present invention is preferably: the 2.5-4.5% Semen Maydis powder, the 0.2-0.8% Zein powder, 0.2-0.8% cottonseed meal, 1.5-2.5% light calcium carbonate, 0.15-0.35% ammonium sulfate, the 0.02-0.05% ferrous sulfate, 0.05-0.25% potassium primary phosphate, 1.5-3.5% corn steep liquor, all the other are water, and this substratum employing quality percentage composition is 30% NaOH aqueous solution adjusting pH to 6.7 ± 0.1.
pressing mass volume ratio calculates, the described fermentation culture based component of d step of the present invention is preferably: the 6-15% Semen Maydis powder, the 2-6% Zein powder, the 0.2-0.8% light calcium carbonate, 0.2-0.8% sodium-chlor, 0.1-0.5% ammonium sulfate, the 0.003-0.012% ferrous sulfate, the 0.007-0.027% potassium primary phosphate, 0.1-0.5% urea, the 0.005-0.015% zinc chloride, 0.05-0.25% potassium hydroxide, the 0.07-0.15% corn steep liquor, 0.1-0.5%L-lactic acid, the high temperature resistant α-amylase of 0.04-0.12%, all the other are water, this substratum employing quality percentage composition is 30% NaOH aqueous solution adjusting pH to 5.9 ± 0.1.
Bacterial strain of the present invention can be used in the production of enramycin.
When being used for enramycin production, be preferably in 28.0 ± 0.5 ℃, under 200 ~ 220 rpm conditions, the DCS067 bacterial strain fermented in fermention medium 9-12 days, make the fermented liquid that contains enramycin; The medium component that fermentation is adopted is preferably the 6-15% Semen Maydis powder, the 2-6% Zein powder, the 0.2-0.8% light calcium carbonate, 0.2-0.8% sodium-chlor, 0.1-0.5% ammonium sulfate, the 0.003-0.012% ferrous sulfate, the 0.007-0.027% potassium primary phosphate, 0.1-0.5% urea, 0.005-0.015% zinc chloride, 0.05-0.25% potassium hydroxide, the 0.07-0.015% corn steep liquor, 0.1-0.5%L-lactic acid, the high temperature resistant α-amylase of 0.04-0.12%, all the other are water, and this substratum employing quality percentage composition is 30% NaOH aqueous solution adjusting pH to 5.9 ± 0.1.
Fungicidal streptomycete DCS067 of the present invention through bacterial strain retrial and study on the stability result as can be known, it has good mitotic stability, during simultaneously for the production of enramycin, can effectively improve the productive rate of enramycin.Its screening method of the method for the invention, easy and simple to handle, reliable results.
Embodiment
The below further illustrates content of the present invention with specific embodiment, but and means never in any form and limit the invention.
The starting strain of the kabicidin streptomycete that following embodiment adopts is available from Chinese common micro-organisms culture presevation administrative center (being numbered 4.1312).
The screening of embodiment 1 enramycin superior strain
A, preparation slant medium: take the 8g maltitol powder, 0.8g dried yeast powder, 0.8g tuna cream, the 1g Tryptones, 3g sodium-chlor, 20g agar, adding water and be settled to 1000ml, is then 30% NaOH aqueous solution adjusting pH to 6.7 ± 0.1 with the quality percentage composition, obtains mixed liquor A.Get above-mentioned mixed liquor A, packing adds successively tampon, two-layer gauze, two-layer kraft paper and wraps to the test tube of some 30 mm * 200 mm, sterilization 20 min under 0.11 ± 0.05MPa, 121 ± 1 ℃ of conditions.Sterilizing shakes up after complete immediately, when being cooled to feel and not scalding, is paved into the inclined-plane, obtains slant medium after solidifying.
Preparation spore suspension I: the starting strain (4.1312) of getting the fungicidal streptomycete, be seeded on above-mentioned slant medium, cultivated 7 days under 28.0 ± 0.5 ℃, relative humidity 40-60% condition, then add the 3mL sterilized water, with the aseptic inoculation pin, spore is scraped, change in the aseptic triangular flask that contains several granulated glass spherees, vibration, the water intaking layer obtains the spore suspension I, adopts spectrophotometry, and its absorbancy is A
600=1.506, spore concentration is 10
12Individual/mL.
B, organic solvent are processed: after phenol, trichloromethane are mixed according to volume ratio 25:4, through the 0.22 organic filtering with microporous membrane degerming of μ m, obtain aseptic organic solvent.Get the spore suspension I that 5mL step a obtains, add the above-mentioned aseptic organic solvent of 5mL, after vibration 30 s on the vortex oscillation device, standing 30 min, layering; Water intaking obtains the spore suspension II mutually, adopts spectrophotometry, and its absorbancy is A
600=0.456.Compare with the spore suspension I, the absorbancy of spore suspension II obviously descends, and is also more clear and bright penetrating in appearance, and glycocalix, protein matter that spore surface is described are combined with organic solvent and have been transferred to organic phase from water afterwards.
C, ultraviolet mutagenesis: get the above-mentioned spore suspension II of 5mL, be placed in the sterile petri dish of diameter 6 cm, be placed with the sterilization rotor in culture dish, culture dish is placed on magnetic stirring apparatus, under agitation condition, vertical range 30cm place's irradiation 45s under the ultraviolet lamp of wavelength 254nm, 30W.
D, preparation contain the isolation medium of Streptomycin sulphate: get the described mixed liquor A of a step, divide by the consumption of 200 mL/ bottles and be filled in the triangular flask that volume is 500 mL, then add successively tampon, two-layer gauze, two-layer kraft paper packing, sterilization 20 min under 0.11 ± 0.05MPa, 121 ± 1 ℃ of conditions.Shake up immediately after sterilization, when being cooled to feel and not scalding, the addition according to every 1mL substratum 0.3 μ g Streptomycin sulphate adds aqueous streptomycin, is down flat plate after again shaking up, and obtains isolation medium after solidifying.
Preparation seed culture medium: take the 35g Semen Maydis powder, the 5g Zein powder, 5g cottonseed meal, 20g light calcium carbonate, 2.5g ammonium sulfate, 0.36g ferrous sulfate, the 1.25g potassium primary phosphate is after adding deionized water and stirring evenly, pour into and carry out gelatinization in boiling water, add the 28g corn steep liquor when being down to room temperature, then be settled to 1000mL with deionized water, regulate pH to 6.7 ± 0.1 with 30% sodium hydroxide solution at last.According to the consumption of 50 mL/ bottles, it is in the triangular flask of 500 mL that limit packing to some volumes are fully stirred on the limit, with tampon, two-layer gauze, the sealing of one deck kraft paper.Sterilization 30 min, obtain seed culture medium after cooling under 121 ± 1 ℃ of conditions of 0.11 ± 0.05MPa.
Preparation fermention medium: take the 120g Semen Maydis powder, 40g Zein powder, 5g light calcium carbonate, 5g sodium-chlor, 3g ammonium sulfate, 0.07g ferrous sulfate, 0.17g potassium primary phosphate, 3g urea, 0.1g zinc chloride, 1.5g potassium hydroxide, after adding the 400mL deionized water and stirring evenly, pour into and carry out gelatinization in 500mL boiling water, then add the high temperature resistant α-amylase of 0.7g to carry out liquefaction processing, add again 1g corn steep liquor and 3g Pfansteihl, add water and be settled to 1000mL; Regulate pH to 5.9 ± 0.1 with 30% sodium hydroxide solution at last.According to the consumption of 50 mL/ bottles, it is in the triangular flask of 500 mL that limit packing to some volumes are fully stirred on the limit, and with the sealing of eight layers of gauze, one deck kraft paper, 30 min that sterilize under 121 ± 1 ℃ of conditions of 0.11 ± 0.05MPa obtain fermention medium after cooling.
Resistance screening: the spore suspension II after c step ultraviolet mutagenesis is processed is diluted to every 1mL and contains 10
-4-10
-7Individual spore is coated on the above-mentioned isolation medium that contains Streptomycin sulphate, cultivates 7 days under 28.0 ± 0.5 ℃, relative humidity 40-60% condition, and first day is just put, and second day rises to be inverted and cultivates, and generates the some single bacterium colony with antibiotic resistance; Respectively the some above-mentioned single bacterium colonies of picking, be inoculated on the slant medium of a step preparation, cultivate 7 days under 28.0 ± 0.5 ℃, relative humidity 40-60% condition after, shovels with inoculation and take approximately 0.5 * 0.5cm
2Be inoculated on above-mentioned seed culture medium, at 28.0 ± 0.5 ℃, after cultivating 28h under 200 ~ 220 rpm conditions, be inoculated on above-mentioned fermention medium, at 28.0 ± 0.5 ℃, cultivated 10 days under 200 ~ 220 rpm conditions, obtain fermented liquid, in the mensuration fermented liquid, enramycin is tired, and tiring is up to 10617U/mL, with its corresponding bacterial strain called after fungicidal streptomycete DCS067.Measure the morphological feature of DCS067, the form of its single bacterium colony is: colony diameter 2-3mm, and spore grey or white, plentiful.The microscopic examination spore is circular or oval.
DCS067 is carried out the sand preservation: add 2 mL sterilized waters in the slant medium of preserving the DCS067 bacterial strain, with inoculating needle, spore is scraped, getting 0.2 mL after shaking up is transferred in blank sand pipe, indicate strain name, preparation date and validity period, be to vacuumize 4-6 h under-750 ~-760 mmHg posts at pressure, sealing is placed in the moisture eliminator that discolour silica gel is housed, in 5 ± 3 ℃ of preservations.Its depositary institution is China Committee for Culture Collection of Microorganisms (CGMCC), and preserving number is CGMCC No.6220, preservation date on June 14th, 2012.
Retrial and the study on the stability of embodiment 2 enramycin superior strains
Bacterial strain retrial: get the sand pipe of preservation DCS067 in embodiment 1, be seeded on the slant medium of embodiment 1 preparation, in 28.0 ± 0.5 ℃, cultivate under relative humidity 40-60% condition after 7 days, take approximately 0.5 * 0.5 cm with the inoculation shovel
2The bacterium layer is seeded on the seed culture medium of embodiment 1 preparation, in 28.0 ± 0.5 ℃, after under 220 rpm conditions, 26-30 h is cultivated in concussion, be forwarded on the fermention medium of embodiment 1 preparation, in 28.0 ± 0.5 ℃, 220 rpm concussions were cultivated 10 days, measured tiring of enramycin in fermented liquid, and result is 10079,11034,10604 U/mL, average 10572 U/mL.This result shows that the DCS067 bacterial strain is active good, and has the characteristic of high yield enramycin.
study on the stability: the sand pipe of getting preservation DCS067 in embodiment 1, be seeded on above-mentioned slant medium, in 28.0 ± 0.5 ℃, cultivate after 7 days under relative humidity 40-60% condition, again be inoculated on above-mentioned slant medium and cultivate, so repeat, after continuous switching three times, be forwarded on above-mentioned seed culture medium, in 28.0 ± 0.5 ℃, after under 220 rpm conditions, 26-30 h is cultivated in concussion, be forwarded in above-mentioned fermention medium, in 28.0 ± 0.5 ℃, 220 rpm concussions were cultivated 10 days, in the detection fermented liquid, terramycin tires, result is 10217, 9805, 10079U/mL, average 10034U/mL.This result shows that DCS067 has mitotic stability.
Embodiment 3 comparative examples
Take starting strain as fermentation strain, adopt the culture condition be equal to embodiment 2 retrials to ferment, detect tiring of enramycin in fermented liquid, result is 7114,7030,7315U/mL, average 7153U/mL.
In comparing embodiment 1, embodiment 3 gained fermented liquids, enramycin is tired as can be known, compares with the strain of setting out, and the productive rate of the enramycin of DCS067 bacterial strain of the present invention has improved 47.80%.
Claims (3)
1. enramycin superior strain, its feature is fungicidal streptomycete (Streptomyces fungicidious) DCS067 in described bacterial strain preservation title, the CGMCC of depositary institution, preserving number are CGMCC No.6220, preservation date on June 14th, 2012.
2. the application of the described bacterial strain of claim 1 in enramycin is produced.
3. the application of bacterial strain in enramycin is produced according to claim 2, is characterized in that, at 28.0 ± 0.5 ℃, under 200 ~ 220 rpm conditions, the DCS067 bacterial strain fermented in fermention medium 9-12 days, makes the fermented liquid that contains enramycin, described fermention medium is pressed mass volume ratio and is calculated, composition is: the 6-15% Semen Maydis powder, the 2-6% Zein powder, the 0.2-0.8% light calcium carbonate, 0.2-0.8% sodium-chlor, 0.1-0.5% ammonium sulfate, the 0.003-0.012% ferrous sulfate, the 0.007-0.027% potassium primary phosphate, 0.1-0.5% urea, the 0.005-0.015% zinc chloride, 0.05-0.25% potassium hydroxide, the 0.07-0.015% corn steep liquor, 0.1-0.5%L-lactic acid, the high temperature resistant α-amylase of 0.04-0.12%, all the other are water, this substratum employing quality percentage composition is 30% NaOH aqueous solution adjusting pH to 5.9 ± 0.1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210399132 CN102864114B (en) | 2012-10-19 | 2012-10-19 | Strain for highly yielding enramycin, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210399132 CN102864114B (en) | 2012-10-19 | 2012-10-19 | Strain for highly yielding enramycin, and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102864114A CN102864114A (en) | 2013-01-09 |
| CN102864114B true CN102864114B (en) | 2013-11-06 |
Family
ID=47443245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210399132 Expired - Fee Related CN102864114B (en) | 2012-10-19 | 2012-10-19 | Strain for highly yielding enramycin, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102864114B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103289938B (en) * | 2013-06-19 | 2014-11-05 | 河北圣雪大成制药有限责任公司 | Streptomycin high-yield strain and screening method thereof |
| CN103740612A (en) * | 2013-12-19 | 2014-04-23 | 河北圣雪大成制药有限责任公司 | High-yield enramycin strain and screening method thereof |
| CN104195203B (en) * | 2014-08-29 | 2017-09-12 | 宁夏泰瑞制药股份有限公司 | A kind of antifungal streptomycete fermentation produces the culture medium and feed process of enramycin |
| CN106148460A (en) * | 2015-04-27 | 2016-11-23 | 牡丹江佰佳信生物科技有限公司 | A kind of fermentation medium improving enramycin B component yield and fermentation process |
| CN105524975A (en) * | 2015-12-24 | 2016-04-27 | 丽珠集团新北江制药股份有限公司 | Detection medium for determining microbiological potency of enramycin |
| JP2020500509A (en) * | 2016-12-06 | 2020-01-16 | インターベット インターナショナル ベー． フェー． | Modified Streptomyces fungisidicus isolates and uses thereof |
| CN109628532A (en) * | 2018-12-30 | 2019-04-16 | 广东容大生物股份有限公司 | Fermentation medium and its application |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101899490A (en) * | 2010-07-14 | 2010-12-01 | 山东胜利股份有限公司 | Method for producing enramycin by using microbial fermentation |
| CN101974469A (en) * | 2010-10-22 | 2011-02-16 | 安徽丰原发酵技术工程研究有限公司 | Streptomyces fungicidious mutant strain and application thereof |
| CN102080056A (en) * | 2009-12-01 | 2011-06-01 | 国家海洋局第三海洋研究所 | New enramycin-producing strain and high-yielding mutant strain thereof |
| CN102154419A (en) * | 2010-12-20 | 2011-08-17 | 安徽丰原发酵技术工程研究有限公司 | Fermentation medium for improving enramycin yield |
-
2012
- 2012-10-19 CN CN 201210399132 patent/CN102864114B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102080056A (en) * | 2009-12-01 | 2011-06-01 | 国家海洋局第三海洋研究所 | New enramycin-producing strain and high-yielding mutant strain thereof |
| CN101899490A (en) * | 2010-07-14 | 2010-12-01 | 山东胜利股份有限公司 | Method for producing enramycin by using microbial fermentation |
| CN101974469A (en) * | 2010-10-22 | 2011-02-16 | 安徽丰原发酵技术工程研究有限公司 | Streptomyces fungicidious mutant strain and application thereof |
| CN102154419A (en) * | 2010-12-20 | 2011-08-17 | 安徽丰原发酵技术工程研究有限公司 | Fermentation medium for improving enramycin yield |
Non-Patent Citations (1)
| Title |
|---|
| 周岷江.恩拉霉素的研究进展.《中国兽药杂志 》.2007,(第12期),42-44. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102864114A (en) | 2013-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102864114B (en) | Strain for highly yielding enramycin, and preparation method and application thereof | |
| CN100390272C (en) | Fluorescent pseudomonads and its fermenting culture process and application | |
| CN102653724B (en) | Lactobacillus casei and application thereof in fermentation production of L-lactic acid | |
| CN106282044B (en) | A kind of preparation method of Hyphomicrobium and pyrroloquinoline quinone | |
| CN103333845B (en) | Pseudomonas chlororaphis and fermenting cultivation method thereof | |
| CN106011022B (en) | A kind of rose yellow streptomycete solid fermentation culture medium and its preparation and fermentation process | |
| CN100406552C (en) | Pantoea agglomerans and fermentation culture method and application thereof | |
| CN103387428A (en) | Preparation method for organic material decomposition agent | |
| CN106434490A (en) | Ginseng bacterium TY15-2 with effects of disease prevention and growth promotion and application thereof | |
| CN106613276A (en) | Artemisia apiacea seedling cultivating method and special trichoderma atroviride fertilizer thereof | |
| CN104430834B (en) | Applications of the Bacillus amyloliquefaciens strain B014 in postharvest fruit and vegetable is fresh-keeping | |
| CN105820974A (en) | Fermenting method of biocontrol actinomycetes and application | |
| CN109182151A (en) | The separating screening method of gingko endogenous fungus | |
| CN103210961A (en) | Biological pesticide for preventing ginseng gray mold and black spot | |
| CN105018395B (en) | One bacillus pumilus and its application in alternaria leaf spot of apple is prevented | |
| CN101724572B (en) | High yield cell wall degrading enzyme and Trichoderme viride of antibacterial peptide and biocontrol reagent thereof | |
| CN101619293B (en) | Streptomyces vinaceusdrappus, filtering method and application | |
| CN108739068A (en) | A kind of production technology of aweto mycelium and fructification | |
| CN110387343B (en) | Solid culture medium for fermentation of streptomyces noursensis and preparation method and application thereof | |
| CN114317670A (en) | Screening culture medium and preparation method and application thereof | |
| CN1163617C (en) | Process for preparing evericin by fermentation method | |
| CN114574384A (en) | Biopesticide extracted from microbial plants and application thereof | |
| CN1543801A (en) | Preparation for biological prevention and cure of hot pepper epidemic disease and method for producing the same | |
| CN106676150A (en) | Method for producing natamycin by using streptomyces gilvosporeus through fermentation | |
| CN114292774A (en) | Mycelium or thallus, application thereof and method for breeding bacterial strain by utilizing mycelium or thallus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 |